• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不适合肺癌筛查患者的分层和管理。

Stratification and management of patients ineligible for lung cancer screening.

机构信息

Division of Medical Oncology, Princess Margaret Cancer Centre, 610 University Ave, Toronto, M5G 2C1, Canada; Dalla Lana School of Public Health, University of Toronto, 155 College St, Toronto, M5T 3M7, Canada; Temerty Faculty of Medicine, University of Toronto, 1 King's College Cir, Toronto, M5S 1A8, Canada.

Division of Medical Oncology, Princess Margaret Cancer Centre, 610 University Ave, Toronto, M5G 2C1, Canada; Temerty Faculty of Medicine, University of Toronto, 1 King's College Cir, Toronto, M5S 1A8, Canada.

出版信息

Respir Med. 2021 Nov;188:106610. doi: 10.1016/j.rmed.2021.106610. Epub 2021 Sep 21.

DOI:10.1016/j.rmed.2021.106610
PMID:34592536
Abstract

This study identifies participants ineligible for lung cancer screening with the greatest likelihood of future eligibility. Lung cancer risk in participants enrolled in longitudinal lung screening was assessed using the Prostate, Lung, Colorectal and Ovarian lung cancer risk calculator (PLCO) at two timepoints: baseline (T) and follow-up (T). Separate analyses were performed on four PLCO eligibility thresholds (3.25%, 2.00%, 1.50%, and 1.00%); only participants with a T risk less than the threshold were included in that analysis. Cox-models identified T risk factors associated with screen-eligibility at T. Three models, applying differing assumptions of participant behavior, predicted future eligibility and were benchmarked against the observed cohort. Nine hundred and fifty-six participants had a T risk <3.25%; at 2.00% n= 755; at 1.50% n= 652; at 1.00% n= 484. Lung cancer risk increased over time in most screen-ineligible participants. However, risk increased much faster in participants who became screen-eligible at T compared to those who remained screen-ineligible (median per-year increase of 0.35% versus 0.02%, when using a 3.25% threshold). Participants smoking for >30 years, current smokers, less educated participants, and those with chronic obstructive pulmonary disease (COPD) at T were significantly more likely to become screen-eligible. New diagnoses of COPD and/or non-lung cancers between T and T precipitated eligibility in a subset of participants. The prediction model that assumed health behaviors observed at T continued to T reasonably predicted changes in lung cancer risk. This prediction model and the identified baseline risk factors can identify screen-ineligible participants who should be closely followed for future eligibility.

摘要

本研究确定了最有可能在未来符合条件的不符合肺癌筛查条件的参与者。在两个时间点(基线[T]和随访[T])使用前列腺癌、肺癌、结直肠癌和卵巢癌风险计算器(PLCO)评估了参加纵向肺部筛查的参与者的肺癌风险。在四个 PLCO 合格性阈值(3.25%、2.00%、1.50%和 1.00%)上分别进行了单独的分析;只有 T 风险低于阈值的参与者才被纳入该分析。Cox 模型确定了与 T 时的筛选资格相关的 T 风险因素。三个模型应用了不同的参与者行为假设,预测了未来的资格,并与观察队列进行了基准测试。956 名参与者的 T 风险<3.25%;在 2.00%时 n=755;在 1.50%时 n=652;在 1.00%时 n=484。在大多数不符合筛查条件的参与者中,肺癌风险随时间增加。然而,与那些一直不符合筛查条件的参与者相比,在 T 时变得符合筛查条件的参与者的风险增加得更快(当使用 3.25%的阈值时,每年中位数增加 0.35%与 0.02%)。在 T 时吸烟>30 年、当前吸烟者、受教育程度较低的参与者和患有慢性阻塞性肺疾病(COPD)的参与者更有可能变得符合筛查条件。在 T 和 T 之间诊断出 COPD 和/或非肺癌会使一部分参与者获得资格。假设在 T 时观察到的健康行为持续到 T 的预测模型合理地预测了肺癌风险的变化。该预测模型和确定的基线风险因素可以识别出不符合筛查条件但应密切关注未来资格的参与者。

相似文献

1
Stratification and management of patients ineligible for lung cancer screening.不适合肺癌筛查患者的分层和管理。
Respir Med. 2021 Nov;188:106610. doi: 10.1016/j.rmed.2021.106610. Epub 2021 Sep 21.
2
When to reinvite initially ineligible populations for targeted lung cancer screening?何时重新邀请最初不符合条件的人群进行目标性肺癌筛查?
BMJ Open Respir Res. 2024 May 15;11(1):e002193. doi: 10.1136/bmjresp-2023-002193.
3
Estimating eligibility for lung cancer screening in an Australian cohort, including the effect of spirometry.估算澳大利亚队列中肺癌筛查的适宜性,包括肺量测定法的影响。
Med J Aust. 2016 Jun 20;204(11):406. doi: 10.5694/mja16.00043.
4
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.用于选择肺癌筛查候选者的风险预测模型:一项回顾性验证研究。
PLoS Med. 2017 Apr 4;14(4):e1002277. doi: 10.1371/journal.pmed.1002277. eCollection 2017 Apr.
5
USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study.USPSTF2013 与 PLCOm2012 肺癌筛查资格标准(国际肺癌筛查试验):前瞻性队列研究的中期分析。
Lancet Oncol. 2022 Jan;23(1):138-148. doi: 10.1016/S1470-2045(21)00590-8. Epub 2021 Dec 11.
6
Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria.解决肺癌筛查资格方面的性别差异:美国预防服务工作组(USPSTF)与PLCOm2012标准对比
Chest. 2022 Jan;161(1):248-256. doi: 10.1016/j.chest.2021.06.066. Epub 2021 Jul 9.
7
Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data.风险预测模型与简化选择标准在确定肺癌筛查资格中的比较:基于德国联邦范围调查和发病数据的分析。
Eur J Epidemiol. 2020 Oct;35(10):899-912. doi: 10.1007/s10654-020-00657-w. Epub 2020 Jun 27.
8
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.采用风险模型进行肺癌筛查的研究对象选择(泛加拿大肺癌早期检测[PanCan]研究):一项单臂前瞻性研究。
Lancet Oncol. 2017 Nov;18(11):1523-1531. doi: 10.1016/S1470-2045(17)30597-1. Epub 2017 Oct 18.
9
Resected Lung Cancer Patients Who Would and Would Not Have Met Screening Criteria.符合和不符合筛查标准的肺癌切除患者。
Ann Thorac Surg. 2016 Jan;101(1):274-9. doi: 10.1016/j.athoracsur.2015.06.010. Epub 2015 Aug 19.
10
Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCO risk prediction tool.确定高危人群进行有针对性的肺癌筛查:PLCO 风险预测工具的独立验证。
Int J Cancer. 2017 Jul 15;141(2):242-253. doi: 10.1002/ijc.30673. Epub 2017 Apr 21.